{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Dr Agarwals Health Care Ltd
Dr Agarwals Health Care Ltd is Rated Hold
Dr Agarwals Health Care Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 June 2026, providing investors with the latest insights into the company’s performance and outlook.
Dr Agarwals Health Care Ltd Shows Mildly Bullish Momentum Amid Technical Shifts
Dr Agarwals Health Care Ltd, a small-cap player in the hospital sector, has recently exhibited a shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite a downgrade in its Mojo Grade from Buy to Hold on 18 March 2026, the stock’s price action and technical indicators suggest nuanced optimism for investors analysing its near-term prospects.
Dr Agarwals Health Care Ltd Technical Momentum Shifts Amid Mixed Market Signals
Dr Agarwals Health Care Ltd has experienced a notable shift in its technical parameters, reflecting a complex interplay of bullish and bearish signals. The stock’s recent price momentum, combined with evolving technical indicators such as MACD, RSI, and moving averages, suggests a transition from a mildly bearish trend to a sideways consolidation phase. This nuanced technical landscape warrants close attention from investors seeking to understand the stock’s near-term trajectory within the hospital sector.
Dr Agarwals Health Care Ltd is Rated Hold
Dr Agarwals Health Care Ltd is rated Hold by MarketsMOJO, with this rating last updated on 18 March 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 15 June 2026, providing investors with the most up-to-date view of the stock’s fundamentals, returns, and market performance.
Dr Agarwals Health Care Ltd is Rated Hold by MarketsMOJO
Dr Agarwals Health Care Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 March 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 04 June 2026, providing investors with the latest insights into its performance and outlook.
Dr Agarwals Health Care Ltd Technical Momentum Shifts Amid Mixed Market Signals
Dr Agarwals Health Care Ltd, a small-cap player in the hospital sector, has experienced a subtle shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a modest day gain of 0.25%, the stock’s technical indicators present a nuanced picture, reflecting both bullish and bearish signals across different timeframes and metrics.
Dr Agarwals Health Care Ltd is Rated Hold
Dr Agarwals Health Care Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 May 2026, providing investors with an up-to-date view of its fundamentals, returns, and overall outlook.
Dr Agarwals Health Care Ltd Gains 6.40%: 4 Key Factors Driving the Week
Dr Agarwals Health Care Ltd delivered a robust weekly gain of 6.40%, significantly outperforming the Sensex’s modest 0.50% rise during 18-22 May 2026. The stock’s price advanced from Rs.450.45 to Rs.479.30, buoyed by a series of technical momentum shifts, mixed market signals, and a strong quarterly earnings report. Despite some volatility and a slight pullback on the final trading day, the overall trend reflected growing investor interest and cautious optimism amid consolidation.
Are Dr Agarwals Health Care Ltd latest results good or bad?
Dr Agarwal's Health Care Ltd reported strong Q4 FY26 results, with a 21.92% increase in net profit to ₹39.71 crores and a 22.57% rise in revenue to ₹564.11 crores, indicating effective growth and operational efficiency despite a slight dip in PAT margin. Overall, the company's performance reflects successful market share gains in the competitive ophthalmology sector.